Biora Therapeutics, Inc.
TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE
Last updated:
Abstract:
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immune modulatory agent (e.g., a CD40/CD40L inhibitor).
Status:
Application
Type:
Utility
Filling date:
30 Mar 2018
Issue date:
13 May 2021